breast cancer index is the modern tool to select patients for extended endocrine therapy
Published 2 years ago • 471 plays • Length 0:51Download video MP4
Download video MP3
Similar videos
-
0:35
how does breast cancer index help with patient selection for extended endocrine therapy?
-
16:19
breast cancer index, extended endocrine therapy | elizabeth ott, pa | 2022 west oncology app updates
-
5:04
standardizing extended endocrine therapy recommendations
-
1:50
challenges with patient selection for extended adjuvant endocrine therapy in breast cancer
-
13:04
breast cancer index (bci)
-
6:09
adjuvant endocrine therapy for breast cancer: optimal durations and regimens
-
1:10:36
updates in extended endocrine therapy for hr breast cancer | asco21 & national practice guidelines
-
10:02
breast cancer: extended adjuvant endocrine therapy
-
3:22
decision-making impact of the breast cancer index
-
56:17
find your finish to anti-estrogen therapy: it starts with the breast cancer index test
-
3:16
what is breast cancer index?
-
20:25
the predictive power of the breast cancer index (h/i) biomarker-sabcs 2022
-
0:52
the role of bci in extended endocrine therapy decision making
-
5:27
breast cancer index patient testimonials
-
1:28
what role do genomic assays play in the decision to extend endocrine therapy?
-
20:13
endocrine treatment in breast cancer
-
0:41
what genomic assay is best suited for the extended endocrine therapy decision?
-
6:23
stratifying patients with breast cancer by a 7-gene assay for endocrine therapy
-
26:34
cdk 4/6 inhibitors in breast cancer advanced and adjuvant settings